analyzed the EF in subjects with T1DM, aged 18–35 years, with a prevalence of ED of 37%, without any differences according to insulin regimens (multidrug injection [MDI] and continuous subcutaneous insulin infusion [CSII]). The gene discussed is INS; the disease is type 1 diabetes mellitus.